Your browser doesn't support javascript.
loading
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Lengfelder, Eva; Görlich, Dennis; Nowak, Daniel; Spiekermann, Karsten; Haferlach, Claudia; Krug, Utz; Kreuzer, Karl-Anton; Braess, Jan; Schliemann, Christoph; Lindemann, Hans-Walter; Horst, Heinz A; Schiel, Xaver; Flasshove, Michael; Hecht, Anna; Schnittger, Susanne; Schneider, Stephanie; Wörmann, Bernhard; Hofmann, Wolf-Karsten; Berdel, Wolfgang E; Bormann, Eike; Sauerland, Cristina; Büchner, Thomas; Hiddemann, Wolfgang.
Afiliação
  • Lengfelder E; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Görlich D; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Nowak D; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Spiekermann K; Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilian-University Munich, Munich, Germany.
  • Haferlach C; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Krug U; Department of Medicine A, Hematology-Oncology, University of Muenster, Muenster, Germany.
  • Kreuzer KA; Department I of Internal Medicine, University at Cologne, Cologne, Germany.
  • Braess J; Community Hospital Barmherzige Brüder, Regensburg, Germany.
  • Schliemann C; Department of Medicine A, Hematology-Oncology, University of Muenster, Muenster, Germany.
  • Lindemann HW; Catholic Hospital, Hagen, Germany.
  • Horst HA; University of Kiel, Kiel, Germany.
  • Schiel X; Community Hospital München-Harlaching, Munich, Germany.
  • Flasshove M; Community Hospital Düren, Düren, Germany.
  • Hecht A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Schnittger S; Munich Leukemia Laboratory (MLL), Munich, Germany.
  • Schneider S; Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilian-University Munich, Munich, Germany.
  • Wörmann B; Department of Hematology and Oncology, Charité University Medicine Berlin, Berlin, Germany.
  • Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.
  • Berdel WE; Department of Medicine A, Hematology-Oncology, University of Muenster, Muenster, Germany.
  • Bormann E; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Sauerland C; Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
  • Büchner T; Department of Medicine A, Hematology-Oncology, University of Muenster, Muenster, Germany.
  • Hiddemann W; Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilian-University Munich, Munich, Germany.
Eur J Haematol ; 100(2): 154-162, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29114972
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha